OrthoSpineNews

MARCH 3, 2025

Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. This event marks the beginning of SST’s U.S.-based

Degenerative Disc Disease 52

Degenerative Disc Disease Patients Spine Clinic 52

OrthoSpineNews

MAY 13, 2025

No serious adverse events (SAEs) were reported, and there was no dose (40X10 6 cells) limiting toxicity at 26-104 weeks. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Clinic Spine 52

ChiroTouch

JULY 19, 2024

SOT (Sacro-Occipital Technique) Blocks Sacro-occipital technique (SOT) blocks are wedge-shaped cushions used in a low-force chiropractic tool to realign the head, spine, and pelvis. Inclinometers Inclinometers measure the range of motion and angles of the spine and other joints. Portable tables. Elevation tables. Traction tables.

X-ray 98

X-ray Soft Tissue Injuries Vertebrae Chiropractic 98

Any Spine

SEPTEMBER 30, 2024

Understanding the Principles of Chiropractic Care Chiropractic care operates on the principle that proper alignment of the spine can positively impact overall health. Enhances Nerve Function Aligning the spine reduces nerve pressure, promoting better overall function and less pain. As the body aligns, so does the mind.

Spinal Adjustment 52

Spinal Adjustment Adjustment Chiropractic Degenerative Disc Disease 52

OrthoSpineNews

MARCH 10, 2025

The results will be presented at the American Society of Pain and Neuroscience (ASPN) annual conference in July 2025, spotlighting Aurora Spines commitment to evidence-based innovation. The REFINE study showcases how Aurora Spine is pushing boundaries, providing hope and tangible improvements for those suffering from debilitating back pain.

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Clinic Musculoskeletal 52

OrthoSpineNews

JUNE 13, 2025

Excellent Safety Profile: No serious adverse events (SAEs) or dose-limiting toxicities reported between 26 and 104 weeks at the target dose (40 million cells). About the BRTX-100 Phase 2 Trial BRTX-100 is a novel, autologous cell-based therapy designed to treat patients suffering from painful lumbosacral disc degeneration.

Degenerative Disc Disease 64

Degenerative Disc Disease Lower Back Pain Clinic Treatment 64

OrthoSpineNews

MAY 14, 2025

Disc/Spine Program In a February podium presentation at the Orthopaedic Research Society (ORS) Annual Meeting, BioRestoratives Vice President of Research and Development, Francisco Silva, presented 2652 week blinded data from the first 15 patients with chronic lumbar disc disease (cLDD) enrolled in the ongoing Phase 2 clinical trial of BRTX-100.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment 52